EUBEATLIN Trademark

Trademark Overview

On Tuesday, October 4, 2022, a trademark application was filed for EUBEATLIN with the United States Patent and Trademark Office. The USPTO has given the EUBEATLIN trademark a serial number of 97618218. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, April 14, 2025. This trademark is owned by Biopeutics Co., Ltd.. The EUBEATLIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of heart disorders and diseases
eubeatlin

General Information

Serial Number97618218
Word MarkEUBEATLIN
Filing DateTuesday, October 4, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, April 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of heart disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiopeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY
Party NameBiopeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY

Trademark Events

Event DateEvent Description
Monday, October 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 15, 2022ASSIGNED TO LIE
Thursday, December 15, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, February 6, 2023ASSIGNED TO EXAMINER
Monday, February 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023SOU EXTENSION 1 FILED
Tuesday, October 17, 2023SOU EXTENSION 1 GRANTED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 2 FILED
Tuesday, April 16, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 14, 2025SOU EXTENSION 4 FILED
Monday, April 14, 2025SOU EXTENSION 4 GRANTED
Tuesday, April 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, October 9, 2024SOU EXTENSION 3 FILED
Monday, April 14, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

eubeatlin disorders diseases heart treatment preparations pharmaceutical